This hypothesis is indirectly confirmed by the observation that Myc signaling is upregulated in proneural GBM tumors, while mesenchymal tumors exploit pathways related to inflammatory response and IL6/JAK/STAT372. This evidence concerns the gene MYC and glioblastoma.